2 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow Oral glucocorticoids: new trials by email Literature Review of Oral glucocorticoids trials Research Report on Oral glucocorticoids
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS Followed by Open-Label Extension (OLE) Period Arumakimig, Placebo, Oral glucocorticoids - VEXAS Syndrome | Phase 2 | Recruiting | Novartis Pharmaceuticals | 120 | 2026-10-30 | 2026-10-13 |
| A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD) JYP0061, Intravenous Glucocorticoids, Oral Glucocorticoids - Neuromyelitis Optica Spectrum Disorders | Phase 2 | Recruiting | Guangzhou JOYO Pharma Co., Ltd | 35 | 2023-05-24 | 2024-11-20 |
Arthralgia (1) · Arthritis (1) · Neuromyelitis Optica (1) · VEXAS syndrome (1)
Guangzhou JOYO Pharma Co., Ltd (1) · Novartis Pharmaceuticals (1)
China (1) · Japan (1)